Karyopharm Therapeutics Inc. (KPTI): Net Income
-$196.04M
Year ended 2025-12-31
-$224.74M
Trailing 12 months to 2026-06-30
| Period ended | Net Income | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | -$196.04M | n/m | 2026-02-13, From 2025-01-01 |
| 2024-12-31 | -$76.42M | n/m | 2026-02-13, From 2024-01-01 |
| 2023-12-31 | -$143.10M | n/m | 2026-02-13, From 2023-01-01 |
| 2022-12-31 | -$165.29M | n/m | 2025-02-19, From 2022-01-01 |
| 2021-12-31 | -$124.09M | n/m | 2024-02-29, From 2021-01-01 |
| 2020-12-31 | -$196.27M | n/m | 2023-02-17, From 2020-01-01 |
| 2019-12-31 | -$199.59M | n/m | 2022-03-01, From 2019-01-01 |
| 2018-12-31 | -$178.41M | n/m | 2021-02-24, From 2018-01-01 |
| 2017-12-31 | -$128.98M | n/m | 2020-02-26, From 2017-01-01 |
| 2016-12-31 | -$109.58M | n/m | 2019-02-28, From 2016-01-01 |
| 2015-12-31 | -$118.18M | n/m | 2018-03-15, From 2015-01-01 |
| 2014-12-31 | -$75.78M | n/m | 2017-03-16, From 2014-01-01 |
| 2013-12-31 | -$33.95M | n/m | 2016-03-15, From 2013-01-01 |
| 2012-12-31 | -$15.89M | n/a | 2015-03-13, From 2012-01-01 |
Net Income at similar companies
| Company | Year ended | Net Income | Change YoY |
|---|---|---|---|
| Karyopharm Therapeutics Inc. (KPTI) | 2025-12-31 | -$196.04M | n/m |
| Elite Pharmaceuticals Inc (ELTP) | 2026-03-31 | $44.87M | n/m |
| Macrogenics Inc (MGNX) | 2025-12-31 | -$74.62M | n/m |
| Heron Therapeutics, Inc. (HRTX) | 2025-12-31 | -$20.20M | n/m |
| Liquidia Corp (LQDA) | 2025-12-31 | -$68.92M | n/m |
| Lifecore Biomedical, Inc. (LFCR) | 2025-05-25 | -$38.72M | n/m |
| Xencor Inc (XNCR) | 2025-12-31 | -$91.92M | n/m |
| Syndax Pharmaceuticals Inc (SNDX) | 2025-12-31 | -$285.42M | n/m |
| Phathom Pharmaceuticals, Inc. (PHAT) | 2025-12-31 | -$221.25M | n/m |
Compare KPTI, ELTP, MGNX, HRTX side by side · Screen every company in Pharmaceutical Preparations ↗